These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19816977)

  • 21. Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
    Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Marume K; Yamamoto M; Ueda M; Yamashita T; Ishibashi-Ueda H; Yasuda S; Ogawa H; Ando Y; Anzai T; Tsujita K
    ESC Heart Fail; 2018 Feb; 5(1):27-35. PubMed ID: 28869340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Typical cardiac magnetic resonance imaging findings of cardiac amyloidosis.
    Floros GV; Karatzis EN; Andreou J; Danias PG
    Hellenic J Cardiol; 2010; 51(5):463-6. PubMed ID: 20876061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic heart failure in patients with cardiac amyloidosis].
    Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
    Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers.
    Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T
    Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An interesting case of cardiac amyloidosis initially diagnosed as hypertrophic cardiomyopathy.
    Boufidou A; Mantziari L; Paraskevaidis S; Karvounis H; Nenopoulou E; Manthou ME; Styliadis IH; Parcharidis G
    Hellenic J Cardiol; 2010; 51(6):552-7. PubMed ID: 21169191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
    Di Giovanni B; Gustafson D; Delgado DH
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Changing Appearance of Cardiac Amyloidosis].
    Mahrholdt H; Klingel K; Sechtem U
    Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic value of high-sensitivity troponin I to predict cardiac causes after syncope/near syncope in emergency department].
    Hainguerlot S
    Ann Cardiol Angeiol (Paris); 2021 Apr; 70(2):86-93. PubMed ID: 33339571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
    Damy T; Plante-Bordeneuve V; Valleix S
    Arch Cardiovasc Dis; 2012 Nov; 105(11):614-5. PubMed ID: 23177490
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atypical left ventricular hypertrophy revealing a rare cause of heart failure in a man from the Comoros Islands].
    Cautela J; Massoure PL; Roche NC; Taix S; Gil JM; Fourcade L
    Med Sante Trop; 2013; 23(4):390-3. PubMed ID: 24412709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
    Kreusser MM; Volz MJ; Knop B; Ehlermann P; Schmack B; Ruhparwar A; Hegenbart U; Schönland SO; Katus HA; Raake PW
    Clin Res Cardiol; 2020 Jun; 109(6):700-713. PubMed ID: 31630214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and management of the cardiac amyloidosis.
    Selvanayagam JB; Hawkins PN; Paul B; Myerson SG; Neubauer S
    J Am Coll Cardiol; 2007 Nov; 50(22):2101-10. PubMed ID: 18036445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiac amyloidosis--cardiovascular magnetic resonance imaging as a valuable diagnostic tool].
    Braun G; Sechtem U; Mahrholdt H
    Dtsch Med Wochenschr; 2009 Apr; 134(15):734-7. PubMed ID: 19340749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic cardiomyopathy complicated with cardiac amyloidosis.
    Kohno I; Komori S; Yamamoto K; Sano S; Ishihara T; Umetani K; Sawanobori T; Ijiri H; Tamura K
    Intern Med; 2000 Aug; 39(8):637-40. PubMed ID: 10939537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk stratification and treatment of cardiac amyloidoses].
    Kristen AV; Schönland SO; Remppis A; Hegenbart U; Schnabel PA; Katus HA; Dengler TJ
    Pathologe; 2009 May; 30(3):212-8. PubMed ID: 19357849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular torsion by two-dimensional speckle tracking echocardiography in patient with a-type amyloid heart disease.
    Karabay CY; Kocabay G
    J Am Soc Echocardiogr; 2011 Jul; 24(7):818.e5-9. PubMed ID: 21074364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
    Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
    Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.